Risk factors and clinical impact associated with infections caused by different types of carbapenem-resistant Klebsiella pneumoniae in China: A clinical study from 2014 to 2017 - 06/09/22
Doi : 10.1016/j.jinf.2022.05.045
Qiaoling Sun a, b, 1, Xuemei Yang c, 1, Yonglu Huang a, Yi Li d, Jianping Lin e, Daihai He f, Congcong Liu a, Sheng Chen c, ⁎ 
, Rong Zhang a, ⁎
, Rong Zhang a, ⁎ a Department of Clinical Laboratory Medicine, Second Affiliated Hospital of Zhejiang University, Hangzhou, China
b Department of Laboratory Medicine, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China
c Department of Infectious Diseases and Public Health, City University of Hong Kong, Kowloon, Hong Kong, China
d Department of Clinical Laboratory Medicine, Henan Provincial People's Hospital, Zhengzhou, China
e Department of Clinical Laboratory Medicine, Wenzhou People's Hospital, Wenzhou, Zhejiang, China
f Department of Applied Mathematics, The Hong Kong Polytechnic University, Hong Kong, China
⁎Corresponding authors.
Keywords : CR-HvKP, Prevalence, Epidemiology, Clinical outcomes, Risk factors, Mortality rate
Le texte complet de cet article est disponible en PDF.
Plan
© 2022
Publié par Elsevier Masson SAS.
Vol 85 - N° 4
P. 436-480 - octobre 2022 Retour au numéro
Article précédent
- Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
- Suvimol Niyomnaitham, Zheng Quan Toh, Paul Vincent Licciardi, Patimaporn Wongprompitak, Kanjana Srisutthisamphan, Katherine Kradangna Copeland, Kulkanya Chokephaibulkit
- COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy
- J.M. Coulson, A. Adams, L.A. Gray, A. Evans
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?